Pediatric Cholesteatoma: Factors Affecting Recurrence Rates and Hearing Outcomes

2017 ◽  
Vol 5 ◽  
pp. 27-32
Author(s):  
Philip Gaudreau ◽  
2016 ◽  
Vol 130 (S3) ◽  
pp. S103-S104
Author(s):  
Enrico Piccirillo ◽  
Flavia D'Orazio ◽  
Sampath Chandra Prasad ◽  
Gianluca Piras ◽  
Mario Sanna

2021 ◽  
Vol 3 (2) ◽  
pp. 140-144
Author(s):  
Mehmet Ozbey BUYUKKUSCU ◽  
Ahmet KULDUK ◽  
Abdurrahman AYDIN ◽  
Engin ÇETİNKAYA ◽  
Şükrü Sarper GÜRSÜ

2021 ◽  
Author(s):  
Hüseyin Sina Coşkun ◽  
◽  
Furkan Erdoğan ◽  
Hikmet Çinka ◽  
Nevzat Dabak ◽  
...  

2019 ◽  
Vol 81 (03) ◽  
pp. 207-212
Author(s):  
Bu-Lang Gao ◽  
Hui Li ◽  
Cong-Hui Li ◽  
Ji-Wei Wang ◽  
Jian-Feng Liu ◽  
...  

Objective Intracranial aneurysms treated with endovascular coil embolization may recur. We investigated the factors affecting aneurysmal recurrence after embolization and effects of endovascular retreatment within 1 year. Methods In 3 years, 1,335 patients with 1,385 intracranial aneurysms were treated with coil embolization. Factors affecting aneurysm recurrence and the effects of endovascular retreatment were analyzed. Results Angiography immediately following embolization showed total occlusion in 1,030 aneurysms (74.4%), neck remnant in 207 (14.9%), and partial occlusion in 148 (10.7%), with a total peri-procedure complication rate of 4.2%. Overall, 145 patients with 151 aneurysms recurred within 1 year and the other 1,234 aneurysms remained occluded (89.1%). A significant (p < 0.05) difference existed in aneurysm size, rupture status, use of stent and immediate occlusion outcome between the two groups, with significantly (p < 0.05) lower recurrence rates in aneurysms with smaller sizes, no rupture and stent-assistance coiling. Neck remnant, partial occlusion, coiling without stent assistance, large and giant aneurysms were significant (p < 0.05) risk factors for aneurysm recurrence during the first year. The rate of recurrence was 4.7% (11/232) in aneurysms with total occlusion and 35.9% (23/64) in aneurysms with neck remnant and partial occlusion. Of the 34 recurrent aneurysms, 6 were re-embolized with detachable coils alone, 12 with stent-assisted coiling, 8 with balloon-assisted embolization, and the remaining 8 aneurysms with covered stents, resulting in total occlusion in 28 aneurysms and neck remnant in 6. Conclusion Recurrence of previously-coiled cerebral aneurysms is significantly affected by aneurysm size, use of stent and degree of immediate occlusion. Endovascular retreatment with balloon-or stent-assisted techniques or with covered stents can be safe and effective for recurrent cerebral aneurysms.


Cancer ◽  
2002 ◽  
Vol 95 (11) ◽  
pp. 2302-2307 ◽  
Author(s):  
Patrick A. Kupelian ◽  
Jeffrey C. Buchsbaum ◽  
Mohamed Elshaikh ◽  
Chandana A. Reddy ◽  
Craig Zippe ◽  
...  

2014 ◽  
Vol 80 (7) ◽  
pp. 680-684 ◽  
Author(s):  
Angel E. Alsina ◽  
Alexia Makris ◽  
Vasilios Nenos ◽  
Eduardo Sucre ◽  
Jade Arrobas ◽  
...  

Recurrence of hepatocellular carcinoma (HCC) remains a main detriment to long-term survival in liver transplants (LTx) for HCC. The study aims to review the use of sorafenib in recurrent HCC LTx in the Model End Stage Liver Disease era. Two hundred forty-seven patients with HCC LTx from 2002 to 2013 were included. Survival was calculated by the Kaplan-Meier (KM) method and Cox multivariate model. Twenty-two patients recurred (11%). By KM, overall survival was 27 months (standard deviation [SD], 3.2 months; median, 28.4 months). Mean time to recurrence was 16.9 months (SD, 2.8 months; median, 12 months). Nine patients were treated with sorafenib after recurrence. Median survival for sorafenib-treated patients was 42 months compared with a median of 16.2 months without sorafenib (-2 log likelihood ratio, P = 0.0582). By Cox, only sorafenib ( P = 0.0233; hazard ratio, 8.528) and pathologic stage had a significant impact on survival. The recurrence rates of HCC LTx remain acceptable considering understaging and expansion of beyond Stage A. This pilot study of sorafenib in recurrent HCC demonstrates improved survival over historic controls. Many other factors affecting improved survival are explained. However, treatment remains palliative. Quality-of-life years and cost analysis need to be performed in this population.


2013 ◽  
Vol 98 (4) ◽  
pp. 319-323 ◽  
Author(s):  
Tayfun Yoldas ◽  
Can Karaca ◽  
Omer Unalp ◽  
Alper Uguz ◽  
Cemil Caliskan ◽  
...  

Abstract Treatment options of pilonidal sinus, which has high recurrence rates, is still controversial. In this study, we aimed to analyze for possible factors affecting recurrence. Forty-one patients with recurrent pilonidal sinus were included in this study. Of them, 33 were male and 9 were female (mean age, 24.9 years; age range, 16–42). Factors (i.e., risk factors) were detected in 32 patients. Excision–secondary healing and lay open was performed on 30 of the patients admitted with recurrence. Excision and flap closure was applied on 11 patients. Our recurrence rate was 9.7%. The recurrence rate of our study is compatible with the literature. Comparative studies are needed to determine the appropriate method to decrease recurrence rate.


2018 ◽  
Author(s):  
Miranda Rogers ◽  
Dawn-Marie Davies ◽  
Jane Halliday ◽  
Aparna Pal ◽  
Anne Marland ◽  
...  

2019 ◽  
Vol 128 (10) ◽  
pp. 956-962
Author(s):  
Sharon Tzelnick ◽  
Dan Yaniv ◽  
Eyal Raveh ◽  
David Ulanovski ◽  
Ohad Hilly

Objectives:The aim of this study was to investigate the audiometric outcomes of tympanomastoidectomy in children with cholesteatoma and to evaluate factors that may affect outcomes.Methods:A retrospective cohort study was conducted. All pediatric patients diagnosed with cholesteatoma who underwent primary canal wall-up tympanomastoidectomy with or without ossicular reconstruction from 2009 to 2016 at a tertiary university-affiliated pediatric medical center were included. Pure tone average (PTA) and air-bone gap (ABG) at 0.5, 1, 2, and 4 kHz were compared before and after surgery.Results:The cohort included 100 children (104 tympanomastoidectomies) of mean age 10.35 ± 3.6 years. The mean duration of follow-up was 35.4 ± 24.1 months. At surgery, 22 patients (21.2%) had intact ossicular chains, and 82 (78.8%) had ossicular discontinuity. Fifty-three patients (51%) underwent ossicular reconstruction, either partial (34 patients [64.1%]) or total (19 patients [35.8%]). In comparison with preoperative audiometry, there was a statistically significant improvement in PTA-ABG at the first postoperative examination (27.5 ± 12.7 vs 21.1 ± 11.1 dB, P = .001) and at the end of follow-up (20.2 ± 12.7 dB, P = .003) . Overall, values of less than 20 dB were measured in 34% of patients preoperatively and 73% postoperatively. On subgroup analysis, in patients who underwent any ossicular reconstruction, PTA-ABG was significantly improved relative to the preoperative value (28.1 ± 14.7 dB) at both the first (19.1 ± 11.9 dB, P = .006) and last (22.4 ± 15.1 dB, P = .011) audiometry examinations.Conclusions:Hearing outcomes after pediatric cholesteatoma surgery are diverse and related to several factors. The authors found that ossicular reconstruction improves audiometric outcomes, and the changes remain stable over time.Level of Evidence:IIB


Sign in / Sign up

Export Citation Format

Share Document